KaloBios Plunges 50 Percent After CEO Martin Shkreli's Arrest

Shkreli, Drug Price-Gouging CEO, Arrested for Fraud

KaloBios Pharmaceuticals Inc. shares lost more than half their value before trading was halted following the arrest Thursday of Chief Executive Officer Martin Shkreli on securities fraud charges related to one of his prior companies.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.